Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Sergey Victorovich Suchkov
Keynote Presentation (In-person)
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Despite breakthroughs in research that have led to an increased understanding of PPM (Personalized & Precision Medicine) based human disease, the translation of discoveries into the areas of diagnostic tools and targeted medicines has not kept pace with medical need. It [....] » Read More

Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Sergey Victorovich Suchkov
Oral Presentation (In-person)
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Biomarkers as being a part of the ligand-receptor tandems have induced an impulse to prompt the development of an upgraded concept of the targeted therapy. So, the identification, impact and im-plementation of diagnostic, predictive and prognostic biomarkers of the next step gene [....] » Read More

Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Braulio Alejandro Martinez Zarco
Oral Presentation (In-person)
Braulio Alejandro Martinez Zarco, UNAM, Mexico

Background: Tumor-associated antigens (TAAs) represent attractive targets for cancer immunotherapy; however, tumor heterogeneity and immune escape remain major challenges for antigen-specific vaccination. Variable Epitope Libraries (VELs) are highly diverse collections of mutated [....] » Read More

Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Jizelle Kay Cofulan Fang Asan
Poster Presentation (In-person)
Jizelle Kay Cofulan Fang Asan, Baguio General Hospital and Medical Center, Philippines

Introduction: Tuberculosis (TB) remains a significant global health threat, affecting approximately 10 million individuals annually, with 1.5 million deaths, making it the leading infectious killer worldwide. Despite the curability of TB, data on the clinical outcomes of patients [....] » Read More

Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Ouikhlef Narjesse
Poster Presentation (In-person)
Ouikhlef Narjesse, EHU Oran & Faculty of Medicine of Oran, Algeria

Background: Primary Sjögren’s syndrome (pSS) is a complex systemic autoimmune disease characterized by significant clinical and biological heterogeneity, driven by intricate genetic and immunological factors. Data regarding North African pSS cohorts remain scarce. This [....] » Read More

Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Abdiche Yasmine
Poster Presentation (In-person)
Abdiche Yasmine, Pasteur Institute of Algeria, Algeria

Antiphospholipid syndrome is an autoimmune disease characterized by vascular thrombosis, obstetric complications, and the presence of antiphospholipid antibodies (aPL). However, diagnosis may be particularly challenging in certain patients who are seronegative for conventional an [....] » Read More

Scientific Programs coming soon..

Speaker at Clinical Immunology, Allergy & Autoimmune Diseases 2027 - Naylya Djumaeva
Oral Presentation (Virtual)
Naylya Djumaeva, Research Institute of Virology, Uzbekistan

Background: Prednisolone and methotrexate are established immunomodulatory agents, but methotrexate is conventionally used at weekly doses substantially higher than those described here. Long-term clinical observations prompted exploration of substantially reduced doses in s [....] » Read More

Watsapp